Alternate case study of topical sulfamylon and silver sulfadiazine in burns.
D000138:Acidosis / Q000209:etiology; D000293:Adolescent; D000328:Adult; D000740:Anemia / Q000209:etiology; D002056:Burns / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology / Q000401:mortality; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D011552:Pseudomonas Infections / Q000188:drug therapy; D011604:Psychoses, Alcoholic / Q000209:etiology; D012131:Respiratory Insufficiency / Q000401:mortality; D012141:Respiratory Tract Infections / Q000209:etiology; D012640:Seizures / Q000209:etiology; D018805:Sepsis / Q000209:etiology; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013411:Sulfadiazine / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D014050:Toluene; D014511:Uremia / Q000209:etiology; D014552:Urinary Tract Infections / Q000209:etiology; D014882:Water-Electrolyte Balance; D014945:Wound Healing / Q000187:drug effects; D014946:Wound Infection / Q000401:mortality
D013449:Sulfonamides; D013411:Sulfadiazine; D014050:Toluene